• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Don't come!

anonymous

Guest
To those talented individuals with the skills to succeed anywhere, keep looking past here.

To those desperate for a job, pursuing a model for self edification, and the adventure of spelunking in deep crevasse of the of the digestive egress of senior ring masters, then this is your place.
 




To those talented individuals with the skills to succeed anywhere, keep looking past here.

To those desperate for a job, pursuing a model for self edification, and the adventure of spelunking in deep crevasse of the of the digestive egress of senior ring masters, then this is your place.
Can you expand on this? Why should this company be avoided at all costs? Top 3 reasons would be nice. And is it just Sales or is mfg or support functions better?
 




1. Shrinking portfolio that relies on one product and one market to carry the company as competition diminishes the profitability.
2. A massive debt to earnings ratio, with decreasing sources to raise working capitol.
3. An eroding quality culture that has impacted product availability, causing an erosion of market share and a dilution of the portfolio.
4. A corporate culture that rewards failure, to protect egos and shield itself for any responsibility in the environment of poor leadership having hollowed out the company of high achievers in the pursuit of a high corporate equity score.